FDA Announces Proposed Collection of Information for User Fee Waivers and Refunds

Summary

The Food and Drug Administration (FDA) is announcing a proposed collection of information for review and clearance under the Paperwork Reduction Act of 1995, seeking user fee waivers, reductions, and refunds for drug and biological products. The submission is being made to the Office of Management and Budget (OMB) for review.